News | Neuro Imaging | September 27, 2017

Brain Disconnections May Contribute to Parkinson's Hallucinations

fMRI study finds areas focused on attention and visual processing more disconnected from the rest of the brain in Parkinson’s patients

Brain Disconnections May Contribute to Parkinson's Hallucinations

September 27, 2017 — Researchers have found that disconnections of brain areas involved in attention and visual processing may contribute to visual hallucinations in individuals with Parkinson’s disease, according to a new study published online in the journal Radiology. The disconnected brain areas seen on functional magnetic resonance imaging (fMRI) may be valuable in predicting the development of visual hallucinations in patients with Parkinson’s disease. 

Hallucinations are sensations that seem real but are created in a person’s mind. A person having a hallucination may see, hear or feel something that is not actually there. According to the National Parkinson Foundation, visual hallucinations can be a complication of Parkinson’s disease.

“Visual hallucinations in Parkinson’s disease are frequent and debilitating,” said study author Dagmar H. Hepp, M.D., from the Department of Neurology and the Department of Anatomy and Neurosciences at VU University Medical Center (VUMC) in Amsterdam, the Netherlands. “Our aim was to study the mechanism underlying visual hallucinations in Parkinson’s disease, as these symptoms are currently poorly understood.”

Studies using fMRI to investigate visual hallucinations in patients with Parkinson’s disease are rare and have been mainly limited to task-based methods using activities that involve visual stimulation or cognitive tasks. However, the authors note that the presence of visual hallucinations is strongly linked to the development of cognitive decline in patients with Parkinson’s disease. Cognitive deficits may influence a patient’s ability to perform specific tasks during an fMRI exam.

For this study, researchers used resting-state fMRI to examine the connectivity, or communication, between brain areas. Resting-state fMRI is a method of brain imaging that can be used to evaluate patients not performing an explicit task. The connectivity was measured in 15 patients with visual hallucinations, 40 patients without visual hallucinations, and 15 healthy controls by calculating the level of synchronization between activation patterns of different brain areas.

The results showed that in all the patients with Parkinson’s disease, multiple brain areas communicated less with the rest of the brain as compared to the control group. However, in patients suffering from visual hallucinations, several additional brain areas showed this decreased connectivity with the rest of the brain, especially those important in maintaining attention and processing of visual information.

“We found that the areas in the brain involved in attention and visual processing were less connected to the rest of the brain,” said study author Menno M. Schoonheim, Ph.D., from the Department of Anatomy and Neurosciences at VUMC. “This suggests that disconnection of these brain areas may contribute to the generation of visual hallucinations in patients with Parkinson’s disease.”

While there are no direct therapeutic implications for patient care based on the research, the authors note that future studies could indicate whether techniques that could stimulate the areas with decreased connectivity could be helpful to treat visual hallucinations in people with Parkinson’s disease.

For more information: www.pubs.rsna.org/journal/radiology

Related Content

Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Medtronic Recalls Synergy Cranial Software and Stealth Station S7 Cranial Software
News | Procedure Navigation Systems | February 05, 2019
Medtronic is recalling the Synergy Cranial Software and StealthStation S7 Cranial Software used with the StealthStation...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...